Runnymede Capital Advisors, Inc. Pfizer Inc Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 80 shares of PFE stock, worth $2,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80Holding current value
$2,042% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PFE
# of Institutions
3,254Shares Held
3.65BCall Options Held
77.7MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA519MShares$13.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.8 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.42 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.18 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.97 Billion0.78% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $143B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...